Key facts
- This page summarizes Matthew T. Wiley's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2025, 16:45.
Matthew T. Wiley - 17 Mar 2025 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- MNMD
- Reported as of
- 17 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 16:45:05 UTC
- Prior SEC filing
- 03 Oct 2024
- Next SEC filing
- 05 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/Mark Sullivan, Attorney-in-Fact for Matthew T. Wiley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew T. Wiley filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 03 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MNMD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +350,000
- Change %
- Price
- $0.000000
- Shares after
- 350,000
- Date
- 17 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 350,000
- Exercise price
- $6.35
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying the option shall vest and become exercisable over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date